NASDAQ:GBIO Generation Bio (GBIO) Stock Forecast, Price & News $3.22 0.00 (0.00%) (As of 10/3/2023 ET) Add Compare Share Share Today's Range$3.16▼$3.3250-Day Range$3.21▼$5.3652-Week Range$3.15▼$7.35Volume88,842 shsAverage Volume105,446 shsMarket Capitalization$211.96 millionP/E RatioN/ADividend YieldN/APrice Target$9.05 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Generation Bio MarketRank™ ForecastAnalyst RatingModerate Buy2.67 Rating ScoreUpside/Downside181.4% Upside$9.05 Price TargetShort InterestBearish4.21% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingSelling Shares$15,362 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($2.05) to ($1.75) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.27 out of 5 starsMedical Sector347th out of 966 stocksPharmaceutical Preparations Industry140th out of 450 stocks 3.3 Analyst's Opinion Consensus RatingGeneration Bio has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 4 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $9.05, Generation Bio has a forecasted upside of 181.4% from its current price of $3.22.Amount of Analyst CoverageGeneration Bio has only been the subject of 3 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted4.21% of the float of Generation Bio has been sold short.Short Interest Ratio / Days to CoverGeneration Bio has a short interest ratio ("days to cover") of 15.6, which indicates bearish sentiment.Change versus previous monthShort interest in Generation Bio has recently increased by 3.02%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldGeneration Bio does not currently pay a dividend.Dividend GrowthGeneration Bio does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for GBIO. Previous Next 2.7 News and Social Media Coverage News SentimentGeneration Bio has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.65 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Generation Bio this week, compared to 1 article on an average week.Search Interest2 people have searched for GBIO on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added Generation Bio to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Generation Bio insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $15,362.00 in company stock.Percentage Held by Insiders20.80% of the stock of Generation Bio is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions95.81% of the stock of Generation Bio is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Generation Bio are expected to grow in the coming year, from ($2.05) to ($1.75) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Generation Bio is -1.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Generation Bio is -1.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioGeneration Bio has a P/B Ratio of 0.68. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Generation Bio (NASDAQ:GBIO) StockGeneration Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.Read More GBIO Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GBIO Stock News HeadlinesSeptember 27, 2023 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Generation Bio (GBIO), Teladoc (TDOC) and Edwards Lifesciences (EW)September 19, 2023 | finance.yahoo.comGeneration Bio to Present at the Jefferies Cell & Genetic Medicine SummitOctober 4, 2023 | Behind the Markets (Ad)[BREAKING] New "Living Missile" to Replace Nuclear MissilesCBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!September 18, 2023 | finance.yahoo.comWe're Not Worried About Generation Bio's (NASDAQ:GBIO) Cash BurnAugust 16, 2023 | msn.comJP Morgan Maintains Generation Bio (GBIO) Neutral RecommendationAugust 7, 2023 | msn.comGeneration Bio: Novel But Preclinical, Interesting But Without DataAugust 7, 2023 | finanznachrichten.deGeneration Bio Co.: Generation Bio Reports Second Quarter 2023 Financial ResultsAugust 3, 2023 | msn.comWedbush Reiterates Generation Bio (GBIO) Outperform RecommendationOctober 4, 2023 | Oxford Club (Ad)Better Than Oil StocksThe best way to profit from energy is NOT a stock...Rather, it's this little-known alternative investment. August 3, 2023 | finance.yahoo.comInsider Buyers Lose US$80k As Generation Bio Sheds US$37mAugust 3, 2023 | benzinga.comGeneration Bio Reports Second Quarter 2023 Financial ResultsAugust 3, 2023 | markets.businessinsider.comJMP Securities Sticks to Its Buy Rating for Generation Bio (GBIO)August 3, 2023 | finance.yahoo.comGeneration Bio to Present at the Canaccord Genuity 43rd Annual Growth ConferenceMay 31, 2023 | finance.yahoo.comGeneration Bio to Present at the 2023 Jefferies Healthcare ConferenceMay 12, 2023 | markets.businessinsider.comJMP Securities Keeps Their Buy Rating on Generation Bio (GBIO)May 11, 2023 | finanznachrichten.deGeneration Bio Co.: Generation Bio Reports Business Highlights and First Quarter 2023 Financial ResultsMay 11, 2023 | markets.businessinsider.comWhere Generation Bio Stands With AnalystsMay 11, 2023 | finance.yahoo.comGeneration Bio Co. (GBIO) Reports Q1 Loss, Misses Revenue EstimatesMay 10, 2023 | finance.yahoo.comGeneration Bio Reports Business Highlights and First Quarter 2023 Financial ResultsApril 20, 2023 | msn.comNeedham Reiterates Generation Bio (GBIO) Buy RecommendationApril 19, 2023 | markets.businessinsider.comThe Latest Analyst Ratings for Generation BioApril 11, 2023 | finance.yahoo.comGeneration Bio to Present at the 22nd Annual Needham Virtual Healthcare ConferenceApril 10, 2023 | finance.yahoo.comHere's Why We're Not At All Concerned With Generation Bio's (NASDAQ:GBIO) Cash Burn SituationApril 5, 2023 | finance.yahoo.comGeneration Bio Appoints Yalonda Howze, J.D. as Chief Legal OfficerMarch 24, 2023 | finance.yahoo.comModerna (MRNA) Inks Genetic Medicines Deal With Generation BioMarch 24, 2023 | benzinga.comWhy Generation Bio Shares Are Trading Higher TodayMarch 23, 2023 | markets.businessinsider.comNeedham Remains a Buy on Generation Bio (GBIO)See More Headlines Receive GBIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Generation Bio and its competitors with MarketBeat's FREE daily newsletter. Email Address GBIO Company Calendar Last Earnings8/02/2023Today10/03/2023Next Earnings (Estimated)11/02/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:GBIO CUSIPN/A CIK1733294 Webgenerationbio.com Phone617-655-7500FaxN/AEmployees150Year FoundedN/APrice Target and Rating Average Stock Price Forecast$9.05 High Stock Price Forecast$14.00 Low Stock Price Forecast$2.23 Forecasted Upside/Downside+181.4%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)($2.08) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-136,640,000.00 Net MarginsN/A Pretax Margin-14,417.16% Return on Equity-45.12% Return on Assets-31.42% Debt Debt-to-Equity RatioN/A Current Ratio12.11 Quick Ratio12.11 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$4.75 per share Price / Book0.68Miscellaneous Outstanding Shares65,930,000Free Float52,216,000Market Cap$211.96 million OptionableNot Optionable Beta2.27 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesDr. Cameron Geoffrey McDonough M.D. (Age 53)Pres, CEO & Director Comp: $939.09kDr. Matthew Norkunas M.B.A. (Age 45)M.D., Chief Financial Officer Comp: $611.11kDr. Matthew Stanton Ph.D. (Age 50)Chief Scientific Officer Comp: $654.83kDr. Douglas Kerr M.B.A. (Age 56)M.D., Ph.D., Chief Medical Officer Comp: $659.1kDr. Tracy Zimmermann Ph.D. (Age 53)Chief Devel. Officer Comp: $622.74kDr. Mark D. Angelino Ph.D. (Age 50)Co-Founder Dr. Robert Kotin Ph.D. (Age 67)Co-Founder Ms. Antoinette Paone M.B.A. (Age 45)M.S., Chief Operating Officer Ms. Yalonda Howze J.D. (Age 51)Chief Legal Officer & Sec. Ms. Jasmin TowerSr. VP of People & OperationsMore ExecutivesKey CompetitorsLifecore BiomedicalNASDAQ:LFCREnanta PharmaceuticalsNASDAQ:ENTANuvectis PharmaNASDAQ:NVCTAstria TherapeuticsNASDAQ:ATXSAC ImmuneNASDAQ:ACIUView All CompetitorsInsiders & InstitutionsBarclays PLCSold 12,791 shares on 9/21/2023Ownership: 0.026%Antoinette PaoneSold 3,116 sharesTotal: $15,361.88 ($4.93/share)California State Teachers Retirement SystemSold 2,815 shares on 8/21/2023Ownership: 0.023%Osaic Holdings Inc.Bought 4,645 shares on 8/21/2023Ownership: 0.007%Nuveen Asset Management LLCSold 8,298 shares on 8/16/2023Ownership: 0.413%View All Insider TransactionsView All Institutional Transactions GBIO Stock - Frequently Asked Questions Should I buy or sell Generation Bio stock right now? 6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Generation Bio in the last twelve months. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" GBIO shares. View GBIO analyst ratings or view top-rated stocks. What is Generation Bio's stock price forecast for 2023? 6 equities research analysts have issued 12 month price targets for Generation Bio's stock. Their GBIO share price forecasts range from $2.23 to $14.00. On average, they predict the company's share price to reach $9.05 in the next twelve months. This suggests a possible upside of 181.4% from the stock's current price. View analysts price targets for GBIO or view top-rated stocks among Wall Street analysts. How have GBIO shares performed in 2023? Generation Bio's stock was trading at $3.93 on January 1st, 2023. Since then, GBIO shares have decreased by 18.2% and is now trading at $3.2150. View the best growth stocks for 2023 here. When is Generation Bio's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023. View our GBIO earnings forecast. How were Generation Bio's earnings last quarter? Generation Bio Co. (NASDAQ:GBIO) released its quarterly earnings data on Wednesday, August, 2nd. The company reported ($0.47) earnings per share for the quarter, beating analysts' consensus estimates of ($0.49) by $0.02. The firm had revenue of $0.88 million for the quarter, compared to analyst estimates of $7.50 million. What other stocks do shareholders of Generation Bio own? Based on aggregate information from My MarketBeat watchlists, some companies that other Generation Bio investors own include DocuSign (DOCU), NVIDIA (NVDA), Overstock.com (OSTK), Boeing (BA), Pure Storage (PSTG), Mastercard (MA), QUALCOMM (QCOM), Riot Platforms (RIOT), Twilio (TWLO) and Enphase Energy (ENPH). When did Generation Bio IPO? (GBIO) raised $126 million in an IPO on Friday, June 12th 2020. The company issued 7,400,000 shares at a price of $16.00-$18.00 per share. J.P. Morgan, Jefferies and Cowen acted as the underwriters for the IPO and Wedbush PacGrow was co-manager. What is Generation Bio's stock symbol? Generation Bio trades on the NASDAQ under the ticker symbol "GBIO." How do I buy shares of Generation Bio? Shares of GBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Generation Bio's stock price today? One share of GBIO stock can currently be purchased for approximately $3.22. How much money does Generation Bio make? Generation Bio (NASDAQ:GBIO) has a market capitalization of $211.96 million. The company earns $-136,640,000.00 in net income (profit) each year or ($2.08) on an earnings per share basis. How many employees does Generation Bio have? The company employs 150 workers across the globe. How can I contact Generation Bio? Generation Bio's mailing address is 301 BINNEY STREET, CAMBRIDGE MA, 02142. The official website for the company is generationbio.com. The company can be reached via phone at 617-655-7500 or via email at investors@generationbio.com. This page (NASDAQ:GBIO) was last updated on 10/4/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Generation Bio Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.